155 related articles for article (PubMed ID: 16014538)
1. Human antiganglioside autoantibodies: validation of ELISA.
Ravindranath MH; Muthugounder S; Saravanan TS; Presser N; Morton DL
Ann N Y Acad Sci; 2005 Jun; 1050():229-42. PubMed ID: 16014538
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
3. Immunology of gangliosides.
Ravindranath MH; Gonzales AM; Nishimoto K; Tam WY; Soh D; Morton DL
Indian J Exp Biol; 2000 Apr; 38(4):301-12. PubMed ID: 11218805
[TBL] [Abstract][Full Text] [Related]
4. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
5. Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.
Ravindranath MH; Muthugounder S; Hannah MR; Morton DL
Ann N Y Acad Sci; 2007 Jun; 1107():212-22. PubMed ID: 17804549
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA.
Ravindranath MH; Ravindranath RM; Morton DL; Graves MC
J Immunol Methods; 1994 Mar; 169(2):257-72. PubMed ID: 7510761
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.
Chu KU; Ravindranath MH; Gonzales A; Nishimoto K; Tam WY; Soh D; Bilchik A; Katopodis N; Morton DL
Cancer; 2000 Apr; 88(8):1828-36. PubMed ID: 10760759
[TBL] [Abstract][Full Text] [Related]
8. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM.
Ravindranath MH; Wood TF; Soh D; Gonzales A; Muthugounder S; Perez C; Morton DL; Bilchik AJ
Cryobiology; 2002 Aug; 45(1):10-21. PubMed ID: 12445546
[TBL] [Abstract][Full Text] [Related]
9. [Antiganglioside antibodies in neuropathies and motor neuronopathies].
Gallardo E; Serrano C; Prat C; Illa I
Neurologia; 1996 Dec; 11 Suppl 5():75-80. PubMed ID: 9044577
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].
Caudie C; Kaygisiz F; Jaquet P; Petiot P; Gonnaud PM; Antoine JC; Vial C
Ann Biol Clin (Paris); 2006; 64(4):353-9. PubMed ID: 16829480
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides elicit a T-cell independent antibody response.
Freimer ML; McIntosh K; Adams RA; Alving CR; Drachman DB
J Autoimmun; 1993 Jun; 6(3):281-9. PubMed ID: 8397712
[TBL] [Abstract][Full Text] [Related]
12. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy.
Shy ME; Heiman-Patterson T; Parry GJ; Tahmoush A; Evans VA; Schick PK
Neurology; 1990 May; 40(5):842-4. PubMed ID: 2330115
[TBL] [Abstract][Full Text] [Related]
13. Sulfatide binding properties of murine and human antiganglioside antibodies.
Townson K; Greenshields KN; Veitch J; Nicholl D; Eckhardt M; Galanina O; Bovin N; Samain E; Antoine T; Bundle D; Zhang P; Ling CC; Willison HJ
Glycobiology; 2007 Nov; 17(11):1156-66. PubMed ID: 17855742
[TBL] [Abstract][Full Text] [Related]
14. IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy.
Giordano N; Lucani B; Amendola A; Geraci S; Santacroce C; Gennari C; Hartini G; Nuti R
Clin Rheumatol; 2003 Sep; 22(3):256-8. PubMed ID: 14505225
[No Abstract] [Full Text] [Related]
15. Antiganglioside antibodies in motor-neuron diseases and peripheral neuropathies: study by ELISA technique and immunodetection on thin-layer chromatography.
Ben Younes-Chennoufi A; Meininger V; Léger JM; Bouche P; Jauberteau MO; Baumann N
Neurochem Int; 1992 Apr; 20(3):353-7. PubMed ID: 1338972
[TBL] [Abstract][Full Text] [Related]
16. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic gangliosides in human ovarian carcinoma.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Santin AD; Bellone S; Saravanan TS; Morton DL
Biochem Biophys Res Commun; 2007 Feb; 353(2):251-8. PubMed ID: 17188646
[TBL] [Abstract][Full Text] [Related]
18. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis.
Sadatipour BT; Greer JM; Pender MP
Ann Neurol; 1998 Dec; 44(6):980-3. PubMed ID: 9851447
[TBL] [Abstract][Full Text] [Related]
19. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies.
Conrad K; Schneider H; Ziemssen T; Talaska T; Reinhold D; Humbel RL; Roggenbuck D
Ann N Y Acad Sci; 2007 Aug; 1109():256-64. PubMed ID: 17785314
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders.
Pestronk A; Adams RN; Kuncl RW; Drachman DB; Clawson LL; Cornblath DR
Neurology; 1989 May; 39(5):628-33. PubMed ID: 2710351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
